Company Filing History:
Years Active: 2025
Title: Melissa Sato: Innovator in Polypeptide Analysis
Introduction
Melissa Sato is a prominent inventor based in Santa Monica, CA. She has made significant contributions to the field of mass spectrometric analysis, particularly in the preparation of polypeptides. Her innovative methods are designed to enhance the analysis of therapeutic polypeptides, which are crucial in various medical applications.
Latest Patents
Melissa holds a patent for her invention titled "Sequential digestion of polypeptides for mass spectrometric analysis." This patent outlines methods for preparing polypeptides for multi-attribute analysis. The disclosed methods involve denaturing, reducing, and/or alkylating polypeptides before subjecting them to a first digestion. Following this, the resulting large and small fragments are separated, and a second digestion is performed on the larger fragments. The final analysis of all fragments can be conducted using chromatographic, electrophoretic, or spectrometric methods, making this approach particularly useful for therapeutic polypeptides that are challenging to cleave. She has 1 patent to her name.
Career Highlights
Melissa is currently employed at Amgen Inc., a leading biotechnology company known for its innovative therapies. Her work at Amgen focuses on advancing the analysis of polypeptides, contributing to the development of new therapeutic solutions.
Collaborations
Melissa collaborates with her coworker, Da Ren, to further enhance the research and development of polypeptide analysis methods.
Conclusion
Melissa Sato's contributions to the field of mass spectrometric analysis through her innovative patent demonstrate her commitment to advancing therapeutic polypeptide research. Her work at Amgen Inc. continues to impact the biotechnology industry positively.